T1D patients depend on exogenous insulin throughout life, and their wellbeing is typically compromised by both hyperglycaemia (a consequence of poor control of the disease) and hypoglycaemia, due to improper insulin treatment [1]. This evidence concerns the gene INS and type 1 diabetes mellitus.